Antifungal Drugs Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Indication, By Drug Class, By Country, & By Region

  • Report Id: HCDHR 1995
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Antifungal Drugs Market Report Overview

Antifungal drugs market garnered a revenue of USD 12.4 billion in the year 2019 globally and has been foreseen to yield USD 14.9 billion by the year 2027 at a compound annual growth (CAGR) of s2.9% over the forecast period. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The antifungal drugs market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Antifungal Drugs Total Available Market (TAM) Size
  • Antifungal Drugs Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights: 

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Antifungal Drugs Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Antifungal Drugs Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Antifungal Drugs Market: Indication Insights
4.1. Global Indication Historic Market Data & Future Forecasts, 2016-2027
4.2. Dermatophytosis
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Aspergillosis
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Candidiasis
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4.3. Invasive Candidiasis
4.4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4.4. Vulvovaginal Candidiasis (VVC)
4.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4.5. Mouth/Throat/Esophageal Candidiasis
4.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4.6. Other Candida Infections
4.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.6.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
4.5. Others
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Antifungal Drugs Market: Drug Class Insights
5.1. Global Drug Class Historic Market Data & Future Forecasts, 2016-2027
5.2. Azoles
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.2.3. Voriconazole (Vfend)
5.2.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.2.4. Posaconazole (Noxafil)
5.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.4.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
5.2.5. Clotrimazole (Canesten)
5.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.2.6. Isavuconazole (CRESEMBA)
5.2.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.2.7. Others
5.2.7.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Echinocandins
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts, By Region, 2016-2027
5.3.3. Caspofungin (Cancidas)
5.3.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3.4. Micafungin (Mycamine/ Funguard)
5.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3.5. Others
5.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4. Polyenes
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4.3. Amphotericin (AmBisome)
5.4.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4.4. Others
5.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.5. Allylamines
5.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.5.3. Terbinafine (Lamisil)
5.5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.5.4. Others
5.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.6. Others
5.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Antifungal Drugs Market: Regional Insights
6.1. Global Antifungal Drugs Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.4.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.6.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.6.4. UAE
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
6.6.5. South Africa
6.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.6.5.3. Historic Market Data & Future Forecasts, By Drug Class, 2016-2027
Chapter 7. Company Profiles
7.1. Bayer AG
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. Glenmark
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. Astellas Pharma, Inc.
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Novartis AG
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. Enzon Pharmaceuticals, Inc.
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. Merck & Co., Inc.
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. Abbott
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. Pfizer, Inc.
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. GlaxoSmithKline plc
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives
7.10. Sanofi
7.10.1. Company Description
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. Strategic Initiatives
List of Tables
Table 1 Antifungal Drugs Market Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 2 Antifungal Drugs Market Data & Future Forecasts, By Region, 2016-2027 (USD Billion)
Table 3 Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 4 Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 5 Dermatophytosis Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 6 Aspergillosis Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 7 Candidiasis Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 8 Invasive Candidiasis Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 9 Vulvovaginal Candidiasis (VVC) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 10 Mouth/Throat/Esophageal Candidiasis Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 11 Other Candida Infections Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 12 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 13 Azoles Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 Voriconazole (Vfend) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 15 Posaconazole (Noxafil) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 16 Clotrimazole (Canesten) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 17 Isavuconazole (CRESEMBA) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 18 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 19 Echinocandins Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 20 Caspofungin (Cancidas) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 21 Micafungin (Mycamine/ Funguard) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 22 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 23 Polyenes Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 24 Amphotericin (AmBisome) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 25 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 26 Allylamines Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 27 Terbinafine (Lamisil) Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 28 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 29 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 30 North America Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 31 North America Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 32 North America Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 33 U.S. Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 34 U.S. Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 35 U.S. Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 36 Canada Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 37 Canada Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 38 Canada Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 39 Europe Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 40 Europe Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 41 Europe Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 42 U.K. Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 43 U.K Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 44 U.K Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 45 Germany Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 46 Germany Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 47 Germany Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 48 France Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 49 France Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 50 France Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 51 Asia Pacific Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 52 Asia Pacific Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 53 Asia Pacific Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 54 China Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 55 China Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 56 China Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 57 India Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 58 India Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 59 India Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 60 Japan Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 61 Japan Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 62 Japan Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 63 South Korea Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 64 South Korea Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 65 South Korea Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 66 Latin America Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 66 Latin America Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 67 Latin America Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 68 Brazil Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 69 Brazil Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 70 Brazil Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 71 Mexico Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 72 Mexico Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 73 Mexico Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 74 Middle East & Africa Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 75 Middle East & Africa Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 76 Middle East & Africa Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 77 UAE Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 78 UAE Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 79 UAE Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
Table 80 South Africa Antifungal Drugs Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 81 South Africa Antifungal Drugs Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 82 South Africa Antifungal Drugs Market Data & Future Forecasts, By Drug Class, 2016-2027 (USD Billion)
List of Figures
Fig.1 Data Analysis Model
Fig.2 Antifungal Drugs Market, by 2016-2027 (USD Billion)
Fig.3 Antifungal Drugs Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Antifungal Drugs Market Driver Anlaysis
Fig.6 Antifungal Drugs Market Restraint Analysis
Fig.7 Antifungal Drugs Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Antifungal Drugs Market
Fig.10 Company Market Share Analysis, 2019

Antifungal Drugs Market Segmentation:

Antifungal Drugs Market, By Indication (2016-2027)

  • Dermatophytosis
  • Aspergillosis
  • Candidiasis
    • Invasive Candidiasis
    • Vulvovaginal Candidiasis (VVC)
    • Mouth/Throat/Esophageal Candidiasis
    • Other Candida Infections
  • Others

Antifungal Drugs Market, By Drug Class (2016-2027)

  • Azoles
    • Voriconazole (Vfend)
    • Posaconazole (Noxafil)
    • Clotrimazole (Canesten)
    • Isavuconazole (CRESEMBA)
    • Others
  • Echinocandins
    • Caspofungin (Cancidas)
    • Micafungin (Mycamine/ Funguard)
    • Others
  • Polyenes
    • Amphotericin (AmBisome)
    • Others
  • Allylamines
    • Terbinafine (Lamisil)
    • Others
  • Others

Antifungal Drugs Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Antifungal Drugs Market:

  • Bayer AG
  • Glenmark
  • Astellas Pharma, Inc.
  • Novartis AG
  • Enzon Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Abbott
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Sanofi

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.